The American Association for Cancer Research (AACR) 2022 meeting was held in New Orleans from April 9 to 13. Doctors and researchers worldwide joined together virtually and in person to make this year’s meeting one of the largest gatherings since the start of the pandemic. They shared the many exciting developments in cancer research and treatment that emerged over the last year.
On May 28, 2021, the United States Food & Drug Administration (FDA) approved sotorasib as the first targeted therapy for patients with KRAS G12C-positive non-small cell lung cancer (NSCLC).
At LUNGevity, we say that our people are our most valuable asset, and our dedicated volunteers exemplify this. Hundreds of volunteers from across the country support LUNGevity and the community we serve. Volunteers use their unique talents and perspectives to provide peer support, raise awareness for lung cancer, plan events and fundraisers, and advocate.
For people with lung cancer, one of the first steps in navigating their diagnosis comes from understanding what their lung cancer stage means for the future of their treatment.
Caregiving may be the most challenging role a person can take on, but also one of the most valuable. In some instances, providing physical and emotional care to a loved one can become a round-the-clock job that may shift other priorities like career or relationships.
On February 10, 2022, the Centers for Medicare & Medicaid Services (CMS) issued a National Coverage Decision to expand reimbursement for lung cancer screening with low-density computed tomography (LDCT).
